The global market for Frovatriptan was estimated to be worth US$ 822 million in 2023 and is forecast to a readjusted size of US$ 1147.2 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Frovatriptan - Market

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Frovatriptan, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Frovatriptan by region & country, by Type, and by Application.

The Frovatriptan market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frovatriptan.

Market Segmentation

Scope of Frovatriptan - Market Report

Report Metric	Details
Report Name	Frovatriptan - Market
Forecasted market size in 2030	US$ 1147.2 million
CAGR	4.9%
Forecasted years	2024 - 2030
Segment by Type:	Hospital Drug Store
Segment by Application	Menstrual Migraines Migraine with Aura Migraine without Aura
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ligand Pharmaceuticals, Endo Pharmaceuticals, Doc Generici, Menarini, Novartis, Almac, Glenmark Generics, Teva, Zambon, Apotex, G.L. Pharma, Chanelle Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Frovatriptan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Frovatriptan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Frovatriptan in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Frovatriptan - Market size in 2030?

Ans: The Frovatriptan - Market size in 2030 will be US$ 1147.2 million.

Who are the main players in the Frovatriptan - Market report?

Ans: The main players in the Frovatriptan - Market are Ligand Pharmaceuticals, Endo Pharmaceuticals, Doc Generici, Menarini, Novartis, Almac, Glenmark Generics, Teva, Zambon, Apotex, G.L. Pharma, Chanelle Pharma

What are the Application segmentation covered in the Frovatriptan - Market report?

Ans: The Applications covered in the Frovatriptan - Market report are Menstrual Migraines, Migraine with Aura, Migraine without Aura

What are the Type segmentation covered in the Frovatriptan - Market report?

Ans: The Types covered in the Frovatriptan - Market report are Hospital, Drug Store

1 Market Overview

1.1 Frovatriptan Product Introduction

1.2 Global Frovatriptan Market Size Forecast

1.2.1 Global Frovatriptan Sales Value (2019-2030)

1.2.2 Global Frovatriptan Sales Volume (2019-2030)

1.2.3 Global Frovatriptan Sales Price (2019-2030)

1.3 Frovatriptan Market Trends & Drivers

1.3.1 Frovatriptan Industry Trends

1.3.2 Frovatriptan Market Drivers & Opportunity

1.3.3 Frovatriptan Market Challenges

1.3.4 Frovatriptan Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Frovatriptan Players Revenue Ranking (2023)

2.2 Global Frovatriptan Revenue by Company (2019-2024)

2.3 Global Frovatriptan Players Sales Volume Ranking (2023)

2.4 Global Frovatriptan Sales Volume by Company Players (2019-2024)

2.5 Global Frovatriptan Average Price by Company (2019-2024)

2.6 Key Manufacturers Frovatriptan Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Frovatriptan Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Frovatriptan

2.9 Frovatriptan Market Competitive Analysis

2.9.1 Frovatriptan Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Frovatriptan Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frovatriptan as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Hospital

3.1.2 Drug Store

3.2 Global Frovatriptan Sales Value by Type

3.2.1 Global Frovatriptan Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Frovatriptan Sales Value, by Type (2019-2030)

3.2.3 Global Frovatriptan Sales Value, by Type (%) (2019-2030)

3.3 Global Frovatriptan Sales Volume by Type

3.3.1 Global Frovatriptan Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Frovatriptan Sales Volume, by Type (2019-2030)

3.3.3 Global Frovatriptan Sales Volume, by Type (%) (2019-2030)

3.4 Global Frovatriptan Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Menstrual Migraines

4.1.2 Migraine with Aura

4.1.3 Migraine without Aura

4.2 Global Frovatriptan Sales Value by Application

4.2.1 Global Frovatriptan Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Frovatriptan Sales Value, by Application (2019-2030)

4.2.3 Global Frovatriptan Sales Value, by Application (%) (2019-2030)

4.3 Global Frovatriptan Sales Volume by Application

4.3.1 Global Frovatriptan Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Frovatriptan Sales Volume, by Application (2019-2030)

4.3.3 Global Frovatriptan Sales Volume, by Application (%) (2019-2030)

4.4 Global Frovatriptan Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Frovatriptan Sales Value by Region

5.1.1 Global Frovatriptan Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Frovatriptan Sales Value by Region (2019-2024)

5.1.3 Global Frovatriptan Sales Value by Region (2025-2030)

5.1.4 Global Frovatriptan Sales Value by Region (%), (2019-2030)

5.2 Global Frovatriptan Sales Volume by Region

5.2.1 Global Frovatriptan Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Frovatriptan Sales Volume by Region (2019-2024)

5.2.3 Global Frovatriptan Sales Volume by Region (2025-2030)

5.2.4 Global Frovatriptan Sales Volume by Region (%), (2019-2030)

5.3 Global Frovatriptan Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Frovatriptan Sales Value, 2019-2030

5.4.2 North America Frovatriptan Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Frovatriptan Sales Value, 2019-2030

5.5.2 Europe Frovatriptan Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Frovatriptan Sales Value, 2019-2030

5.6.2 Asia Pacific Frovatriptan Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Frovatriptan Sales Value, 2019-2030

5.7.2 South America Frovatriptan Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Frovatriptan Sales Value, 2019-2030

5.8.2 Middle East & Africa Frovatriptan Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Frovatriptan Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Frovatriptan Sales Value

6.2.1 Key Countries/Regions Frovatriptan Sales Value, 2019-2030

6.2.2 Key Countries/Regions Frovatriptan Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Frovatriptan Sales Value, 2019-2030

6.3.2 United States Frovatriptan Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Frovatriptan Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Frovatriptan Sales Value, 2019-2030

6.4.2 Europe Frovatriptan Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Frovatriptan Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Frovatriptan Sales Value, 2019-2030

6.5.2 China Frovatriptan Sales Value by Type (%), 2023 VS 2030

6.5.3 China Frovatriptan Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Frovatriptan Sales Value, 2019-2030

6.6.2 Japan Frovatriptan Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Frovatriptan Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Frovatriptan Sales Value, 2019-2030

6.7.2 South Korea Frovatriptan Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Frovatriptan Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Frovatriptan Sales Value, 2019-2030

6.8.2 Southeast Asia Frovatriptan Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Frovatriptan Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Frovatriptan Sales Value, 2019-2030

6.9.2 India Frovatriptan Sales Value by Type (%), 2023 VS 2030

6.9.3 India Frovatriptan Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Ligand Pharmaceuticals

7.1.1 Ligand Pharmaceuticals Company Information

7.1.2 Ligand Pharmaceuticals Introduction and Business Overview

7.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Ligand Pharmaceuticals Frovatriptan Product Offerings

7.1.5 Ligand Pharmaceuticals Recent Development

7.2 Endo Pharmaceuticals

7.2.1 Endo Pharmaceuticals Company Information

7.2.2 Endo Pharmaceuticals Introduction and Business Overview

7.2.3 Endo Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Endo Pharmaceuticals Frovatriptan Product Offerings

7.2.5 Endo Pharmaceuticals Recent Development

7.3 Doc Generici

7.3.1 Doc Generici Company Information

7.3.2 Doc Generici Introduction and Business Overview

7.3.3 Doc Generici Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Doc Generici Frovatriptan Product Offerings

7.3.5 Doc Generici Recent Development

7.4 Menarini

7.4.1 Menarini Company Information

7.4.2 Menarini Introduction and Business Overview

7.4.3 Menarini Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Menarini Frovatriptan Product Offerings

7.4.5 Menarini Recent Development

7.5 Novartis

7.5.1 Novartis Company Information

7.5.2 Novartis Introduction and Business Overview

7.5.3 Novartis Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Novartis Frovatriptan Product Offerings

7.5.5 Novartis Recent Development

7.6 Almac

7.6.1 Almac Company Information

7.6.2 Almac Introduction and Business Overview

7.6.3 Almac Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Almac Frovatriptan Product Offerings

7.6.5 Almac Recent Development

7.7 Glenmark Generics

7.7.1 Glenmark Generics Company Information

7.7.2 Glenmark Generics Introduction and Business Overview

7.7.3 Glenmark Generics Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Glenmark Generics Frovatriptan Product Offerings

7.7.5 Glenmark Generics Recent Development

7.8 Teva

7.8.1 Teva Company Information

7.8.2 Teva Introduction and Business Overview

7.8.3 Teva Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Teva Frovatriptan Product Offerings

7.8.5 Teva Recent Development

7.9 Zambon

7.9.1 Zambon Company Information

7.9.2 Zambon Introduction and Business Overview

7.9.3 Zambon Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Zambon Frovatriptan Product Offerings

7.9.5 Zambon Recent Development

7.10 Apotex

7.10.1 Apotex Company Information

7.10.2 Apotex Introduction and Business Overview

7.10.3 Apotex Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Apotex Frovatriptan Product Offerings

7.10.5 Apotex Recent Development

7.11 G.L. Pharma

7.11.1 G.L. Pharma Company Information

7.11.2 G.L. Pharma Introduction and Business Overview

7.11.3 G.L. Pharma Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.11.4 G.L. Pharma Frovatriptan Product Offerings

7.11.5 G.L. Pharma Recent Development

7.12 Chanelle Pharma

7.12.1 Chanelle Pharma Company Information

7.12.2 Chanelle Pharma Introduction and Business Overview

7.12.3 Chanelle Pharma Frovatriptan Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Chanelle Pharma Frovatriptan Product Offerings

7.12.5 Chanelle Pharma Recent Development

8 Industry Chain Analysis

8.1 Frovatriptan Industrial Chain

8.2 Frovatriptan Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Frovatriptan Sales Model

8.5.2 Sales Channel

8.5.3 Frovatriptan Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Ligand Pharmaceuticals

List of Tables

Table 1. Frovatriptan Market Trends

Table 2. Frovatriptan Market Drivers & Opportunity

Table 3. Frovatriptan Market Challenges

Table 4. Frovatriptan Market Restraints

Table 5. Global Frovatriptan Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Frovatriptan Revenue Market Share by Company (2019-2024)

Table 7. Global Frovatriptan Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Frovatriptan Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Frovatriptan Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Frovatriptan Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Frovatriptan Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Frovatriptan

Table 13. Global Frovatriptan Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frovatriptan as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Frovatriptan Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Frovatriptan Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Frovatriptan Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Frovatriptan Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Frovatriptan Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Frovatriptan Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Frovatriptan Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Frovatriptan Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Frovatriptan Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Frovatriptan Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Frovatriptan Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Frovatriptan Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Frovatriptan Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Frovatriptan Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Frovatriptan Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Frovatriptan Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Frovatriptan Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Frovatriptan Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Frovatriptan Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Frovatriptan Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Frovatriptan Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Frovatriptan Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Frovatriptan Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Frovatriptan Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Frovatriptan Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Frovatriptan Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Frovatriptan Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Frovatriptan Sales Value by Region (2019-2024) & (%)

Table 44. Global Frovatriptan Sales Value by Region (2025-2030) & (%)

Table 45. Global Frovatriptan Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Frovatriptan Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Frovatriptan Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Frovatriptan Sales Volume by Region (2019-2024) & (%)

Table 49. Global Frovatriptan Sales Volume by Region (2025-2030) & (%)

Table 50. Global Frovatriptan Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Frovatriptan Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Frovatriptan Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Frovatriptan Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Frovatriptan Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Frovatriptan Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Frovatriptan Sales Volume, (2025-2030) & (K Units)

Table 57. Ligand Pharmaceuticals Company Information

Table 58. Ligand Pharmaceuticals Introduction and Business Overview

Table 59. Ligand Pharmaceuticals Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Ligand Pharmaceuticals Frovatriptan Product Offerings

Table 61. Ligand Pharmaceuticals Recent Development

Table 62. Endo Pharmaceuticals Company Information

Table 63. Endo Pharmaceuticals Introduction and Business Overview

Table 64. Endo Pharmaceuticals Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Endo Pharmaceuticals Frovatriptan Product Offerings

Table 66. Endo Pharmaceuticals Recent Development

Table 67. Doc Generici Company Information

Table 68. Doc Generici Introduction and Business Overview

Table 69. Doc Generici Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Doc Generici Frovatriptan Product Offerings

Table 71. Doc Generici Recent Development

Table 72. Menarini Company Information

Table 73. Menarini Introduction and Business Overview

Table 74. Menarini Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Menarini Frovatriptan Product Offerings

Table 76. Menarini Recent Development

Table 77. Novartis Company Information

Table 78. Novartis Introduction and Business Overview

Table 79. Novartis Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Novartis Frovatriptan Product Offerings

Table 81. Novartis Recent Development

Table 82. Almac Company Information

Table 83. Almac Introduction and Business Overview

Table 84. Almac Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Almac Frovatriptan Product Offerings

Table 86. Almac Recent Development

Table 87. Glenmark Generics Company Information

Table 88. Glenmark Generics Introduction and Business Overview

Table 89. Glenmark Generics Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Glenmark Generics Frovatriptan Product Offerings

Table 91. Glenmark Generics Recent Development

Table 92. Teva Company Information

Table 93. Teva Introduction and Business Overview

Table 94. Teva Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Teva Frovatriptan Product Offerings

Table 96. Teva Recent Development

Table 97. Zambon Company Information

Table 98. Zambon Introduction and Business Overview

Table 99. Zambon Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Zambon Frovatriptan Product Offerings

Table 101. Zambon Recent Development

Table 102. Apotex Company Information

Table 103. Apotex Introduction and Business Overview

Table 104. Apotex Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Apotex Frovatriptan Product Offerings

Table 106. Apotex Recent Development

Table 107. G.L. Pharma Company Information

Table 108. G.L. Pharma Introduction and Business Overview

Table 109. G.L. Pharma Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. G.L. Pharma Frovatriptan Product Offerings

Table 111. G.L. Pharma Recent Development

Table 112. Chanelle Pharma Company Information

Table 113. Chanelle Pharma Introduction and Business Overview

Table 114. Chanelle Pharma Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Chanelle Pharma Frovatriptan Product Offerings

Table 116. Chanelle Pharma Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Frovatriptan Downstream Customers

Table 120. Frovatriptan Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Frovatriptan Product Picture

Figure 2. Global Frovatriptan Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Frovatriptan Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Frovatriptan Sales Volume (2019-2030) & (K Units)

Figure 5. Global Frovatriptan Sales Price (2019-2030) & (US$/Unit)

Figure 6. Frovatriptan Report Years Considered

Figure 7. Global Frovatriptan Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Frovatriptan Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Frovatriptan Revenue in 2023

Figure 10. Frovatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Hospital Picture

Figure 12. Drug Store Picture

Figure 13. Global Frovatriptan Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Frovatriptan Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Frovatriptan Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Frovatriptan Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Frovatriptan Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Menstrual Migraines

Figure 19. Product Picture of Migraine with Aura

Figure 20. Product Picture of Migraine without Aura

Figure 21. Global Frovatriptan Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Frovatriptan Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Frovatriptan Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Frovatriptan Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Frovatriptan Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Frovatriptan Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Frovatriptan Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Frovatriptan Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Frovatriptan Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Frovatriptan Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Frovatriptan Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Frovatriptan Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Frovatriptan Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Frovatriptan Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Frovatriptan Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Frovatriptan Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Frovatriptan Sales Volume (%), (2019-2030)

Figure 38. United States Frovatriptan Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Frovatriptan Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Frovatriptan Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Frovatriptan Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Frovatriptan Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Frovatriptan Sales Value by Application (%), 2023 VS 2030

Figure 44. China Frovatriptan Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Frovatriptan Sales Value by Type (%), 2023 VS 2030

Figure 46. China Frovatriptan Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Frovatriptan Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Frovatriptan Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Frovatriptan Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Frovatriptan Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Frovatriptan Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Frovatriptan Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Frovatriptan Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Frovatriptan Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Frovatriptan Sales Value by Application (%), 2023 VS 2030

Figure 56. India Frovatriptan Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Frovatriptan Sales Value by Type (%), 2023 VS 2030

Figure 58. India Frovatriptan Sales Value by Application (%), 2023 VS 2030

Figure 59. Frovatriptan Industrial Chain

Figure 60. Frovatriptan Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9U15196

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14K1494

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions